To ensure that manufacturing significantly influences the development of new drugs, a multifaceted approach is essential. This includes fostering collaboration between pharmaceutical manufacturers, researchers, and regulatory bodies to align manufacturing capabilities with innovative drug design. Implementing advanced manufacturing technologies, such as continuous processing and automation, can enhance efficiency and scalability while ensuring product quality. Additionally, integrating feedback loops from manufacturing into the early stages of drug development can help identify potential production challenges and optimize formulations accordingly. Emphasizing a culture of quality by design (QbD) will further ensure that manufacturing considerations are embedded throughout the drug development process. We will discuss:

• How to improve collaboration between Manufacturing and R&D?
• How can Manufacturing contribute to faster and less costly new drug product introductions?
• What role does company culture play?
• How can we lead the organization(s) towards end-to-end process thinking and ownership?